In a sign of strong demand, China's largest retail drugstore chain China Nepstar priced its offering of roughly 20.6 million ADS at $16.20, far above its originally proposed $11.50-$13.50 range. We attribute investors' strong appetite for the deal to the company's tremendous opportunities in a fast-growing market. Goldman Sachs lead managed the offering, and the stock is expected to commence trading on the NYSE under the ticker symbol "NPD" on Friday.
